- Home
- KALV vs ULH Comparison
KALV vs ULH Comparison
Compare KALV & ULH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KALV
- ULH
- Stock Information
- Founded
- KALV N/A
- ULH 1932
- Country
- KALV United States
- ULH United States
- Employees
- KALV N/A
- ULH N/A
- Industry
- KALV Biotechnology: Pharmaceutical Preparations
- ULH Trucking Freight/Courier Services
- Sector
- KALV Health Care
- ULH Industrials
- Exchange
- KALV Nasdaq
- ULH Nasdaq
- Market Cap
- KALV 651.3M
- ULH 591.6M
- IPO Year
- KALV N/A
- ULH 2005
- Fundamental
- Price
- KALV $12.92
- ULH $23.60
- Analyst Decision
- KALV Strong Buy
- ULH Hold
- Analyst Count
- KALV 8
- ULH 1
- Target Price
- KALV $24.83
- ULH $29.00
- AVG Volume (30 Days)
- KALV 498.7K
- ULH 37.1K
- Earning Date
- KALV 07-10-2025
- ULH 07-24-2025
- Dividend Yield
- KALV N/A
- ULH 1.78%
- EPS Growth
- KALV N/A
- ULH N/A
- EPS
- KALV N/A
- ULH 3.17
- Revenue
- KALV N/A
- ULH $1,736,518,000.00
- Revenue This Year
- KALV N/A
- ULH N/A
- Revenue Next Year
- KALV N/A
- ULH $7.88
- P/E Ratio
- KALV N/A
- ULH $7.45
- Revenue Growth
- KALV N/A
- ULH 1.16
- 52 Week Low
- KALV $7.30
- ULH $20.60
- 52 Week High
- KALV $15.50
- ULH $53.29
- Technical
- Relative Strength Index (RSI)
- KALV 60.56
- ULH 43.96
- Support Level
- KALV $11.11
- ULH $22.40
- Resistance Level
- KALV $11.93
- ULH $24.72
- Average True Range (ATR)
- KALV 0.60
- ULH 0.84
- MACD
- KALV 0.05
- ULH -0.01
- Stochastic Oscillator
- KALV 80.09
- ULH 28.99
About KALV KalVista Pharmaceuticals Inc.
KalVista Pharmaceuticals Inc is a pharmaceutical company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema and diabetic macular edema; and oral plasma kallikrein inhibitors. Geographically it operates throughout the region of the United States. The company is also conducting preclinical development on a novel, oral, Factor XIIa inhibitor program.
About ULH Universal Logistics Holdings Inc.
Universal Logistics Holdings Inc is an asset-light provider of customized transportation and logistics solutions throughout the United States, and in Mexico, Canada and Colombia. It offers services such as truckload, brokerage, intermodal, dedicated, and value-added services. The company reports into four segments namely trucking, intermodal, company-managed brokerage, and contract logistics. The majority of the revenue is earned from the contract logistics segment.